Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
Go back to Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron| Pfizer Inc. (NYSE: PFE) | Delayed: 24.17 -0.08 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.25 | 52 Week High | $37.39 | |||
| Open | $24.34 | 52 Week Low | $28.25 | |||
| Day High | $24.41 | P/E | 14.65 | |||
| Day Low | $24.10 | EPS | $1.65 | |||
| Volume | 27,519,596 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 24.17 -0.08 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.25 | 52 Week High | $37.39 | |||
| Open | $24.34 | 52 Week Low | $28.25 | |||
| Day High | $24.41 | P/E | 14.65 | |||
| Day Low | $24.10 | EPS | $1.65 | |||
| Volume | 27,519,596 | |||||
